Cargando…
Evolving a national clinical trials learning health system
Clinical trials generate key evidence to inform decision making, and also benefit participants directly. However, clinical trials frequently fail, often struggle to enroll participants, and are expensive. Part of the problem with trial conduct may be the disconnected nature of clinical trials, preve...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10091198/ https://www.ncbi.nlm.nih.gov/pubmed/37066100 http://dx.doi.org/10.1002/lrh2.10327 |
_version_ | 1785023102727487488 |
---|---|
author | Stensland, Kristian D. Richesson, Rachel L. Vince, Randy A. Skolarus, Ted A. Sales, Anne E. |
author_facet | Stensland, Kristian D. Richesson, Rachel L. Vince, Randy A. Skolarus, Ted A. Sales, Anne E. |
author_sort | Stensland, Kristian D. |
collection | PubMed |
description | Clinical trials generate key evidence to inform decision making, and also benefit participants directly. However, clinical trials frequently fail, often struggle to enroll participants, and are expensive. Part of the problem with trial conduct may be the disconnected nature of clinical trials, preventing rapid data sharing, generation of insights and targeted improvement interventions, and identification of knowledge gaps. In other areas of healthcare, a learning health system (LHS) has been proposed as a model to facilitate continuous learning and improvement. We propose that an LHS approach could greatly benefit clinical trials, allowing for continuous improvements to trial conduct and efficiency. A robust trial data sharing system, continuous analysis of trial enrollment and other success metrics, and development of targeted trial improvement interventions are potentially key components of a Trials LHS reflecting the learning cycle and allowing for continuous trial improvement. Through the development and use of a Trials LHS, clinical trials could be treated as a system, producing benefits to patients, advancing care, and decreasing costs for stakeholders. |
format | Online Article Text |
id | pubmed-10091198 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-100911982023-04-13 Evolving a national clinical trials learning health system Stensland, Kristian D. Richesson, Rachel L. Vince, Randy A. Skolarus, Ted A. Sales, Anne E. Learn Health Syst Commentaries Clinical trials generate key evidence to inform decision making, and also benefit participants directly. However, clinical trials frequently fail, often struggle to enroll participants, and are expensive. Part of the problem with trial conduct may be the disconnected nature of clinical trials, preventing rapid data sharing, generation of insights and targeted improvement interventions, and identification of knowledge gaps. In other areas of healthcare, a learning health system (LHS) has been proposed as a model to facilitate continuous learning and improvement. We propose that an LHS approach could greatly benefit clinical trials, allowing for continuous improvements to trial conduct and efficiency. A robust trial data sharing system, continuous analysis of trial enrollment and other success metrics, and development of targeted trial improvement interventions are potentially key components of a Trials LHS reflecting the learning cycle and allowing for continuous trial improvement. Through the development and use of a Trials LHS, clinical trials could be treated as a system, producing benefits to patients, advancing care, and decreasing costs for stakeholders. John Wiley and Sons Inc. 2022-08-03 /pmc/articles/PMC10091198/ /pubmed/37066100 http://dx.doi.org/10.1002/lrh2.10327 Text en © 2022 The Authors. Learning Health Systems published by Wiley Periodicals LLC on behalf of University of Michigan. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
spellingShingle | Commentaries Stensland, Kristian D. Richesson, Rachel L. Vince, Randy A. Skolarus, Ted A. Sales, Anne E. Evolving a national clinical trials learning health system |
title | Evolving a national clinical trials learning health system |
title_full | Evolving a national clinical trials learning health system |
title_fullStr | Evolving a national clinical trials learning health system |
title_full_unstemmed | Evolving a national clinical trials learning health system |
title_short | Evolving a national clinical trials learning health system |
title_sort | evolving a national clinical trials learning health system |
topic | Commentaries |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10091198/ https://www.ncbi.nlm.nih.gov/pubmed/37066100 http://dx.doi.org/10.1002/lrh2.10327 |
work_keys_str_mv | AT stenslandkristiand evolvinganationalclinicaltrialslearninghealthsystem AT richessonrachell evolvinganationalclinicaltrialslearninghealthsystem AT vincerandya evolvinganationalclinicaltrialslearninghealthsystem AT skolarusteda evolvinganationalclinicaltrialslearninghealthsystem AT salesannee evolvinganationalclinicaltrialslearninghealthsystem |